医学
神经纤维瘤病
儿科
干预(咨询)
生活质量(医疗保健)
人口
重症监护医学
病理
精神科
环境卫生
护理部
作者
David T. Miller,Debra Freedenberg,Elizabeth K. Schorry,Nicole J. Ullrich,David Viskochil,Bruce R. Korf,Emily Chen,Tracy L. Trotter,Susan A. Berry,Leah W. Burke,Timothy A. Geleske,Rizwan Hamid,Robert J. Hopkin,Wendy J. Introne,Michael J. Lyons,Angela E. Scheuerle,Joan M. Stoler
出处
期刊:Pediatrics
[American Academy of Pediatrics]
日期:2019-04-22
卷期号:143 (5)
被引量:201
标识
DOI:10.1542/peds.2019-0660
摘要
Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system. Its population prevalence is approximately 1 in 3000. The condition is usually recognized in early childhood, when pigmentary manifestations emerge. Although NF1 is associated with marked clinical variability, most children affected follow patterns of growth and development within the normal range. Some features of NF1 can be present at birth, but most manifestations emerge with age, necessitating periodic monitoring to address ongoing health and developmental needs and minimize the risk of serious medical complications. In this report, we provide a review of the clinical criteria needed to establish a diagnosis, the inheritance pattern of NF1, its major clinical and developmental manifestations, and guidelines for monitoring and providing intervention to maximize the health and quality of life of a child affected.
科研通智能强力驱动
Strongly Powered by AbleSci AI